IRulya Therapeutics, Inc. (IRLA)
39.94
-0.65
(-1.60%)
USD |
NASDAQ |
Nov 19, 16:00
39.12
-0.82
(-2.05%)
Pre-Market: 20:00
IRulya Therapeutics EPS Diluted (Quarterly) : -2.311 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -2.311 |
| June 30, 2026 | -12.31 |
| March 31, 2026 | 78.15 |
| December 31, 2025 | -141.62 |
| September 30, 2025 | -49.83 |
| June 30, 2025 | -68.75 |
| March 31, 2025 | -0.342 |
| December 31, 2024 | -56.78 |
| September 30, 2024 | -0.1272 |
| June 30, 2024 | -0.6434 |
| March 31, 2024 | -0.2592 |
| December 31, 2023 | -0.2171 |
| September 30, 2023 | -0.1483 |
| June 30, 2023 | -0.136 |
| March 31, 2023 | -0.3418 |
| December 31, 2022 | -0.1531 |
| September 30, 2022 | -0.2224 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.5102 |
| March 31, 2022 | -0.7182 |
| December 31, 2021 | -0.7812 |
| September 30, 2021 | -0.7292 |
| June 30, 2021 | -0.7352 |
| March 31, 2021 | -0.7811 |
| December 31, 2020 | -0.6958 |
| September 30, 2020 | -0.7293 |
| June 30, 2020 | -0.5982 |
| March 31, 2020 | -0.6078 |
| December 31, 2019 | -0.4607 |
| September 30, 2019 | -0.3673 |
| June 30, 2019 | -0.5718 |
| March 31, 2019 | -0.2116 |
| June 30, 2018 | -23.16 |
| March 31, 2018 | -0.1258 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | -3.432 |
| PepGen Inc. | -0.28 |
| Q32 Bio, Inc. | -0.2622 |
| Bridgebio Oncology Therapeutics, Inc. | -0.4262 |
| Oncolytics Biotech, Inc. | -0.0759 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.74M |
| Total Expenses (Quarterly) | 27.74M |
| Enterprise Value | 79.19M |
| Earnings Yield | -195.5% |
| Normalized Earnings Yield | -197.55 |